Published time: 30 April 2020
Authors: Adrien Sanchez, Pierre Sohier, Sarah Benghanem, Anne-Sophie L’Honneur, PharmD, Flore Rozenberg, Nicolas Dupin, Bethsabée Garel
Keywords: Covid-19, Italian study, digitate, dermatologic.
In December 2019 in Wuhan, China, a novel coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), caused an international outbreak of respiratory illness termed coronavirus disease 2019 (COVID-19). Common symptoms include fever, fatigue, cough, and shortness of breath.1 Although most cases result in mild symptoms, it is estimated that around 5% of patients develop severe pneumonia and multiorgan failure.2 A recent Italian study3 reported a spectrum of cutaneous eruptions with nonspecific features in more than 20% of a small cohort of patients with COVID-19. We report a case of a digitate papulosquamous eruption occurring during a SARS-CoV-2 infection.
Digitate Papulosquamous Eruption Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection